Immunostaining of monoclonal antibody O13 [anti-MIC2 gene product (CD99)] in lymphomas: Impact of heat-induced epitope retrieval

Applied Immunohistochemistry and Molecular Morphology

Volumn 4, Issue 1, 1996, Pages 43-55

  Vartanian, Robert K ^a   Sudilovsky, Daniel ^a   Weidner, Noel ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen retrieval; CD99; Ewing's sarcoma; Hodgkin's disease; Lymphoma; MIC2 gene; Neuroepithelioma

Indexed keywords

CD99 ANTIGEN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MAJOR CLINICAL STUDY; MICROWAVE RADIATION; PRIORITY JOURNAL;

EID: 0029870266     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Fellinger EJ, Garin-Chesa P, Su SL, DeAngelis P, Lane JM, Rettig WJ. Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell surface antigen. Cancer Res 1991;51:336-40.
2. Dracopoli NC, Rettig WJ, Albino AP, et al. Genes controlling gp25/30 cell-surface molecules map to chromosome X and Y and escape X-inactivation. Am J Hum Genet 1985;37: 199-207.
3. MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994;18: 486-94.
4. Bodger MP, Francis GE, Delia D, Granger SM, Janossy G. A monoclonal antibody specific for immature human hemopoietic cells and T lineage cells. J Immunol 1981;127: 2269-74.
5. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991;67:1886-93.
6. Hamilton G, Fellinger EJ, Schratter I, Fritsch A. Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen. Cancer Res 1988;48:6127-31.
7. Rettig WJ, Garin-Chesa P, Huvos AG. Ewing's sarcoma: new approaches to histogenesis and molecular plasticity [Editorial]. Lab Invest 1992;66:133-7.
8. MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker. Review of more than 600 tumors and the literature experience. Appl Immunohistochem 1994;2:231-40.
9. Levy R, Dilley J, Fox RI, Warnke R. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci 1979;76:6552-6.
10. MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone. Am J Surg Pathol 1992;16:746-55.
11. MIC2. Am J Pathol 1991;139:317-25.
12. 2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma. Hum Pathol 1993;24:880-5.
13. Perlman EJ, Dickman OS, Askin FB, Grier HE, Miser JS, Link MP. Ewing's sarcoma-routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup study. Hum Pathol 1994;25:304-7.
14. Lumadue JA, Askin FB, Perlman EJ. MIC2 analysis of small cell carcinoma. Am J Clin Pathol 1994;102:692-4.
15. Ramani P, Rampling D, Link M. Immunocytochemical study of 12E7 in small round-cell tumors of childhood: an assessment of its sensitivity and specificity. Histopathology 1993; 23:557-61.
16. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994;25:396-9.
17. Soslow RA, Bhargava V, Warnke RA. 12E7 reactivity distinguishes lymphoblastic lymphoma from small non-cleaved cell lymphoma [Abstract 702]. Mod Pathol 1995;8:121A.
18. Dworzak MN, Fritsch G, Buchinger P, et al. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 1994;83:415-25.
19. Shin HJC, Hin DM, Shah T, Ro JY. Optimization of proliferating cell nuclear antigen immunohistochemical staining by microwave heating in zinc sulfate solution. Mod Pathol 1994;7:242-8.
20. Cooper K, Haffajee Z. Immunohistochemical assessment of MIC2 gene product in granulocytic sarcoma using six epitope retrieval systems. Appl Immunohistochem 1995;3: 198-201.
21. Taylor CR, Shi SR, Chaiwum B, Young L, Imam SA, Cote RJ. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 1994;25:263-70.
22. Ho J, Shintaku IP, Preston M, Said JW. Can microwave antigen retrieval replace frozen section immunohistochemistry in the phenotyping of lymphoid neoplasms? A comparative study of kappa and lambda light chain staining in frozen sections, B5-fixed paraffin sections, and microwave urea antigen retrieval. Appl Immunohistochem 1994;2: 282-6.
23. Tenaud C, Negoescu A, Labat-Moleur, Legros Y, Soussi T, Brambilla E. p53 immunolabeling in archival paraffin-embedded tissues: optimal protocol based on microwave heating for eight antibodies on lung carcinomas. Mod Pathol 1994;7:853-9.
24. Leong ASY, Milios J. An assessment of the efficacy of the microwave antigen-retrieval procedure on a range of tissue antigens. Appl Immunohistochem 1993;1:267-74.
25. Terada T, Shimizu K, Izumi R, Nakanuma Y. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections. Mod Pathol 1994;7:249-52.
26. Gown AM, de Wever N, Battifora H. Microwave-based antigenic unmasking. A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1993; 1:256-66.
27. Goldberg DE, Stuart J, Koerner FC. Progesterone receptor detection in paraffin sections of human breast cancers by an immunoperoxidase technique incorporating microwave heating. Mod Pathol 1994;7:401-6.
28. Beckstead JH. Improved antigen retrieval in formalin-fixed, paraffin-embedded tissues. Appl Immunohistochem 1994;2: 274-81.
29. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
30. Leong ASY. Malignant lymphoma: nomenclature, recently recognized subtypes, and current concepts. J Histotech 1992;15:175-84.
31. Deegan MJ. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing. Arch Pathol Lab Med 1989;113:606-18.
32. Harris NL, Jaffe ES, Stein J, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
33. Perkins SL, Kjeldsberg CR. Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues. Am J Clin Pathol 1993;99:362-73.
34. Nathwani BN, Mohrmann RL, Brynes RK, Taylor CR, Hansmann ML, Sheibani K. Monocytoid B-cell lymphomas: an assessment of diagnostic criteria and a perspective on histogenesis. Hum Pathol 1992;23:1061-71.
35. Nizze H, Cogliatti SB, Schilling CV, Feller AC, Lennert K. Monocytoid B-cell lymphoma: morphological variants and relationship to low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue. Histopathology 1991;18:403-14.
36. Mollejo M, Menarguez J, Cristobal E, et al. Monocytoid B cells. A comparative clinical pathological study of their distribution in different types of low-grade lymphomas. Am J Surg Pathol 1994;18:1131-9.
37. Medeiros LJ. Intermediate and high-grade diffuse non-Hodgkin's lymphomas in the Working Formulation. In: Jaffe ES, ed. Surgical pathology of the lymph nodes and related organs. Philadelphia: WB Saunders, 1995:283-343.
38. van Eyken P, de Wolf-Peeters C, van den Oord J, Tricott G, Desmet V. Expression of leukocyte common antigen in lymphoblastic lymphoma and small noncleaved undifferentiated non-Burkitt's lymphoma: an immunohistochemical study. J Pathol 1987;151:257-61.
39. Weiss LM, Bindl J, Picozzi VJ, Link MP, Warnke RA. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T-cell acute lymphoblastic leukemia. Blood 1986;67:474-8.
40. Weiss LM, Arber DA, Chang KL. CD45: a review. Appl Immnnohistochem 1993;1:166-81.
41. Weidner N. CD45 immunostaining in lymphoblastic lymphoma [Letter to the Editor]. Am J Surg Pathol 1995;19: 733-4.
42. Arber DA, Weiss LM. CD43: a review. Appl Immunohistochem 1993;1:88-96.